Ace2 Spike S Protein

Spike S protein library
SB043 0.5
EUR 2326.75
Description: Spike (S) glycoprotein corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.With a 1 273 aa length, Spike protein has 2 subunits : S1 contains the receptor-binding domain RBD and S2 induces the fusion of the viral envelop with the cellular membrane. The S1 subunit allows binding to the Angiotensin-Converting Enzyme receptor 2 (ACE2 receptor) which mediates the viral entry.Spike (S) is a glycoprotein of 1 273 aa length. sb-PEPTIDE offers a library made of 316 peptides with a length of 15 amino acids and an overlap of 11 amino acids without post-translational modificaton.

Human IgG antibody Laboratories manufactures the ace2 spike s protein reagents distributed by Genprice. The Ace2 Spike S Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Ace2 products are available in stock. Specificity: Ace2 Category: Spike Group: S Protein

MERS-CoV Spike (S) protein
5x0.1mg
EUR 1570

Spike S biotin protein library
0.5
EUR 2603.74
Description: Biotinylated version of the Spike (S) glycoprotein which corresponds to one of the leading targets for COVID-19 disease. Present on the surface of Sars-CoV-2 virus, Spike S protein is a class I fusion protein that allows the virus to enter host cells.

Bovine Coronavirus Spike Protein (BCoV S) Antibody
0.1 mg
EUR 350

Human COVID-19 Spike Protein IgG ELISA Kit
N/A Ask for price
Description: N/A

Human coronavirus OC43 Spike glycoprotein (S)
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10ug
  • 50ug
  • 100ug
  • 200ug
  • 500ug
  • 1MG
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in E.coli

Human coronavirus OC43 Spike glycoprotein (S)
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10ug
  • 50ug
  • 100ug
  • 200ug
  • 500ug
  • 1MG
Description: Recombinant Human coronavirus OC43 Spike glycoprotein(S) ,partial expressed in Yeast

Spike S peptide pool
15 nmol
EUR 409.06
Description: Spike S peptide is a peptide pool made of 15-mer peptides with 11–amino acid (aa) overlap, covering the complete sequence of the Spike S protein.

Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
0.1mg
EUR 1240

Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
0.5mg
EUR 3045

Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
1mg
EUR 4355

Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
5x1mg
EUR 19595

Recombinant Human Novel Coronavirus Spike glycoprotein (S) Protein
0.1mg
EUR 1240

S Protein information

SARS COV2 Spike protein S Trimer Recombinant
MBS553730-025mg 0.25mg
EUR 1570

Bovine Coronavirus Spike Protein (BCoV S) Antibody
abx137748-01mg 0.1 mg
EUR 350

SARS Associated Spike Mosaic S Protein
20-abx260156
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S Protein
abx260156-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S Protein
abx260156-5g 5 µg
EUR 350

ACE2: Spike S1 RBD (SARS-CoV-2) Inhibitor Screening Assay Kit
79936 96 rxns.
EUR 660
Description: The ACE2:SARS-CoV-2 Spike Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of bound Fc-tagged Spike protein by HRP-labeled Anti-Fc. Only a few simple steps on a microtiter plate are required for the assay. First, ACE2 protein is attached to a nickel-coated 96-well plate. Next, SARS-CoV-2 Spike-Fc is incubated with ACE2 on the plate. Finally, the plate is treated with Anti-Fc-HRP followed by addition of an HRP substrate to produce chemiluminescence, which then can be measured using a chemiluminescence reader.

SARS-CoV-2 Spike Protein (S Protein) Polyclonal Antibody
EGVR1001 2019-nCoV-rabbit-polyclonal-antibody
EUR 276.5
Description: 2019-nCoV rabbit polyclonal antibody

SARS-CoV-2 Spike Protein (S Protein) Polyclonal Antibody
MBS8574969-01mg 0.1mg
EUR 475

SARS-CoV-2 Spike Protein (S Protein) Polyclonal Antibody
MBS8574969-5x01mg 5x0.1mg
EUR 1985

Spike S1 (B.1.617 Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78288 384 rxns.
EUR 1070
Description: The Spike S1 (B.1.617 Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between Spike S1 (B.1.617) (SARS-CoV-2) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1 (B.1.618 Variant) (SARS-CoV-2): ACE2 TR-FRET Assay Kit
78289 384 rxns.
EUR 1070
Description: The Spike S1 (B.1.618 Variant) (SARS-CoV-2): ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between Spike S1 (B.1.618) (SARS-CoV-2) and human ACE2 in a homogeneous 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, and the dye-labeled acceptor for one hour. Then the TR-FRET signal is measured using a fluorescence reader capable of measuring Time Resolved-Fluorescence Resonance Energy Transfer (TR-FRET).

Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit
79949-1 96 rxns.
EUR 905
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ 

Spike S1-Biotin (SARS-CoV-2): ACE2 TR-FRET Assay Kit
79949-2 384 rxns.
EUR 1265
Description: The pandemic coronavirus disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection._x000D_The SARS-CoV-2 Spike S1:ACE2 TR-FRET Assay is designed to measure the inhibition of the binding between SARS-CoV-2 Spike S1 and human ACE2 in a homogeneous 96 or 384 reaction format. This TR-FRET-based assay requires no time-consuming washing steps, making it especially suitable for high throughput screening applications. The assay procedure is straightforward and simple; the test inhibitor compound is incubated with biotinylated Spike S1, Eu-labeled ACE2, dye-labeled acceptor and an inhibitor for one hour. Then the TR-FRET signal is measured using a fluorescence reader._x000D_ 

2019 nCoV/COVID19 Spike protein S Recombinant-His
MBS553721-01mg 0.1mg
EUR 490

2019 nCoV/COVID19 Spike protein S Recombinant-His
MBS553721-05mg 0.5mg
EUR 1570

2019 nCoV/COVID19 Spike protein S Recombinant-His
MBS553721-5x05mg 5x0.5mg
EUR 6775

SARS Associated Spike Mosaic S(M) Protein
20-abx260155
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S(M) Protein
abx260155-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S(M) Protein
abx260155-5g 5 µg
EUR 350

SARS Associated Spike Mosaic S(N) Protein
20-abx260157
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S(N) Protein
abx260157-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S(N) Protein
abx260157-5g 5 µg
EUR 350

Spike S1 RBD (SARS-CoV-2): ACE2 Inhibitor Screening Assay Kit
79931 96 rxns.
EUR 675
Description: The SARS-CoV-2 Spike:ACE2 Inhibitor Screening Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of bound His-labeled ACE2 by HRP-labeled Anti-His. Only a few simple steps on a microtiter plate are required for the assay. First, SARS-CoV-2 Spike is coated on a 96-well plate. Next, ACE2-His is incubated with SARS-CoV-2 Spike on the plate. Finally, the plate is treated with Anti-His-HRP followed by addition of an HRP substrate to produce chemiluminescence, which then can be measured using a chemiluminescence reader.

Biotinylated SARS COV2 Spike protein S Trimer Recombinant
MBS553736-002mg 0.02mg
EUR 515

Biotinylated SARS COV2 Spike protein S Trimer Recombinant
MBS553736-01mg 0.1mg
EUR 1435

ACE2:Spike RBD (SARS-CoV-2) Inhibitor Screening Colorimetric Assay Kit
78031 96 rxns.
EUR 630
Description: Coronavirus disease 2019 (COVID-19) increases the risk of developing Acute Respiratory Distress Syndrome (ARDS), which is often fatal at the late stages of the infection when the SAR-CoV-2 virus causes significant damage to the lungs. As a first step of the viral replication strategy, the virus attaches to the host cell surface before entering the cell. The Spike protein receptor binding domain (RBD) recognizes and attaches to the Angiotensin-Converting Enzyme 2 (ACE2) receptor found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Drugs targeting the interaction between the Spike protein of SARS-CoV-2 and ACE2 may offer some protection against the viral infection.The ACE2:SARS-CoV-2 Spike (RBD) Inhibitor Screening Colorimetric Assay Kit is designed for screening and profiling inhibitors of this interaction. The key to this kit is the high sensitivity of detection of Fc-tagged Spike protein by HRP-labeled Anti-mouse-Fc. Only a few simple steps on a microtiter plate are required for the assay. First, ACE2 protein is attached to a clear nickel-coated 96-well plate. Next, SARS-CoV-2 Spike-Fc is incubated with ACE2 on the plate. Finally, the plate is treated with HRP-labeled anti-Fc, followed by addition of an HRP substrate to produce color, which can then be measured using a UV/Vis spectrophotometer microplate reader.

COV2 Spike protein S B.1.1.529 (Omicron) Biotinylated-His
MBS553746-002mg 0.02mg
EUR 490

COV2 Spike protein S B.1.1.529 (Omicron) Biotinylated-His
MBS553746-01mg 0.1mg
EUR 1570